Rabies and Pre-Exposure Vaccination: Why Most Travellers Underestimate This Risk

Rabies is one of the most reliably fatal infections known to medicine. Once clinical neurological symptoms appear, there is no effective treatment and the case fatality rate is essentially 100 percent. Yet despite this, it is consistently underestimated by travellers and frequently omitted from pre-travel health planning, often with the assumption that avoiding obviously sick animals provides sufficient protection.

This guide explains why that assumption is clinically dangerous, who should consider pre-exposure vaccination, and what pre-exposure immunisation does and does not mean in practice.

What Is Rabies and How Is It Transmitted?

Rabies is a fatal viral encephalitis caused by the rabies virus, a member of the Rhabdoviridae family. It is transmitted almost exclusively through the saliva of an infected animal, typically through a bite, though transmission via scratches that break the skin or contact with mucous membranes (eyes, nose or mouth) has been documented.

Dogs are responsible for approximately 99 percent of human rabies deaths globally, predominantly in Asia and sub-Saharan Africa. Bats are the primary reservoir in the Americas and account for most human rabies deaths in Western Europe and the United States. Foxes, jackals, raccoons, monkeys and cats can also transmit the virus. Importantly, infected animals are not always visibly sick. An animal that is behaving normally can still be incubating the virus and shedding it in saliva.

Globally, rabies causes an estimated 59,000 deaths per year, with the highest burden in India and across sub-Saharan Africa and Southeast Asia. Children are disproportionately affected because they are more likely to interact with animals and less likely to report a bite or scratch.

Why Animal Avoidance Is Not a Sufficient Prevention Strategy

The assumption that sensible avoidance of animals eliminates rabies risk is understandable but flawed. In many endemic regions, free-roaming dogs are ubiquitous in urban and rural settings and may approach travellers without provocation. Children in particular may interact with animals impulsively. Cyclists, runners and trekkers in rural areas have a higher incidence of unprovoked animal approaches.

More critically, even minor animal contact that the traveller does not initially consider significant, a scratch during play, contact with a dog’s mouth, a lick on broken skin, may constitute a potential exposure requiring urgent post-exposure prophylaxis. The psychological barrier to seeking immediate medical care is lower when a traveller has received pre-exposure vaccination.

Pre-Exposure Vaccination: What It Does and Does Not Provide

Pre-exposure rabies vaccination does not provide complete, permanent immunity to rabies. This is a critical point that is often misunderstood. Its clinical purpose is different: it simplifies and extends the window for effective post-exposure treatment.

An unvaccinated person bitten by a potentially rabid animal requires both rabies immunoglobulin (RIG) and a course of post-exposure rabies vaccine, given according to a specific schedule starting as soon as possible, ideally within 24 hours. Rabies immunoglobulin is a biological product that is frequently unavailable in developing countries and, when available, is expensive and may not meet WHO quality standards. This logistical problem is the core argument for pre-exposure vaccination.

A person who has received pre-exposure rabies vaccination requires only two doses of post-exposure vaccine and does not require immunoglobulin. This dramatically simplifies the post-exposure response and, critically, extends the time available to receive it to 48 to 72 hours rather than immediately, which matters enormously in settings where access to a properly equipped medical facility takes time.

The Pre-Exposure Vaccine Course

The standard pre-exposure rabies vaccine course requires three doses, given at day zero, day seven and day 21 or 28. This means that ideally, the course is started at least four weeks before travel. An abbreviated two-dose accelerated schedule (day zero and day seven) may provide sufficient priming in urgent situations but offers less certainty and requires clinical discussion.

Rabies vaccine is well tolerated. Mild side effects including injection site soreness and low-grade fever occur in a minority of recipients. Booster doses for occupationally exposed individuals are guided by antibody titre monitoring; for leisure travellers, current UKHSA guidance indicates that pre-exposure vaccination provides lasting priming and additional boosters before each trip are not routinely necessary in most travellers.

What to Do After a Potential Exposure

If you are bitten or scratched by an animal in a rabies-endemic country, wash the wound thoroughly with soap and running water for a minimum of 15 minutes immediately. This simple measure significantly reduces the viral load at the wound site. Irrigate with an iodine-based antiseptic if available. Then seek medical attention urgently, even if you have been pre-exposure vaccinated.

Do not wait to see if symptoms develop. By the time rabies symptoms appear, the infection is beyond treatment. The same applies when returning to the UK: any potential exposure should be reported to a clinician immediately on return or earlier if you have any concern.

This article is for general information purposes and does not constitute individual clinical advice. To discuss rabies vaccination for your specific travel itinerary, please book a travel health consultation at Halton Pharmacy in Leeds.